| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |